Revolutionizing Pharmaceutical Marketing Effectiveness with Change Management and Technology
Any analysis of future market trends starts from a thorough and accurate understanding of current market conditions, based on the most complete and reliable source of industry data - the reporting companies themselves, in their SEC filings and Annual Reports.
Forecasting the commercial performance of a drug or a pharma company is as much an art as a science, but one widely used measure of future value is the investment analyst consensus forecast, compiled from the reports published by leading financial analysts and brokers.
EvaluatePharma brings together historic sales and detailed company financials with investment analyst consensus sales forecasts in a user-friendly, online service, to deliver unique insight into the past and future performance of the pharmaceuticals and biotechnology sector.
Helping you to make better business decisions
To find out how EvaluatePharma can help you to make better business decisions, visit www.evaluatepharma.com
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.